ZDHHC1 Inhibitors

ZDHHC1, or zinc finger DHHC-type containing 1, is an integral component of the protein palmitoylation process-a post-translational modification that attaches a palmitate, a 16-carbon saturated fatty acid, to specific proteins. This modification plays pivotal roles in protein-protein interactions, protein-membrane associations, and protein stability. ZDHHC1, situated primarily in the Golgi apparatus and endoplasmic reticulum membrane, holds palmitoyltransferase activity, enabling the transfer of the palmitate to target proteins. This enzyme takes part in a myriad of cellular processes, from antiviral innate immune responses to the positive regulation of defense against viruses.

The inhibitors that target ZDHHC1 and its enzymatic functions are of keen interest in the field of biochemistry. These molecules generally function by impeding the palmitoyltransferase activity of ZDHHC1. One common inhibitory mechanism is by mimicking the natural substrates of the enzyme, effectively competing with them, thus obstructing the palmitoylation process. Another set of inhibitors might act allosterically-binding to sites on the ZDHHC1 enzyme distinct from the active site, inducing a conformational change that diminishes its activity. A different category could obstruct the enzyme's access to its substrates, either by binding to the substrate itself or by causing steric hindrance. Inhibitors might also act by disrupting the enzyme's associations with the membranes of the Golgi apparatus or endoplasmic reticulum, making it unavailable for substrate interactions. The objective of these compounds is to modulate the activity of ZDHHC1 in order to investigate its functions, elucidate its role in various cellular processes, and understand the implications of its dysregulation.